To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Health119-hr1492 — To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.. Sponsored by Rep. Murphy, Gregory F. [R-NC-3]. Introduced 2025-02-21. House bill. 119th Congress. Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsor
- Rep. Murphy, Gregory F. [R-NC-3] (R), NC
- Introduced
- 2025-02-21
- Committees
- Ways and Means Committee; Energy and Commerce Committee
- Subjects
- Health care costs and insurance; Medicare; Prescription drugs
- Latest Action
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
No roll-call vote data available for this bill.
Similar Bills
- 118-hr7174 — To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. 86% match 118th Congress
- 119-hr1171 — SAFE Act 49% match
- 119-hr3792 — KIDS Act 49% match
- 119-hr2538 — CARE Act of 2025 49% match
- 119-hr3222 — SMART Health Care Act 48% match
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis